AI and Resolving the Heterogeneity of Psychiatric Disease Taxonomy
The assessment tools used by psychiatrists have
Expert Joseph Geraci, holder of the PhD and MS degrees and associate with NetraMark as Chief Technology Officer, Chief Scientific Officer and founder, outlined how artificial intelligence (AI) can support both drug development and clinical practice in psychiatry.
Health news
Exercise and Mood: Italian Study Links Physical Activity to Lower Depression Symptoms
Screen Time in Childhood Linked to Unexpected Cognitive Boost in Teens, 8‑Year Study Shows
Workplace stress and anxiety are taking a heavy toll on employees, with one in three workers reporting that the strain is not easing
Daily Food Habit Tied to Lower Risk of Anxiety and DepressionAn important perspective of Geraci underlines that while AI has significant potential in discovering active substances through biochemistry, it cannot fully solve the complexity of biology because the possible combinations are extremely elaborate. He observed that the fundamental obstacle was often not molecular structure, but rather the classification of disease. This heterogeneity implies that a single medicinal product often had to simultaneously target several distinct conditions.
The methodology developed by Geraci focused on using mathematical procedures that improved the computational capabilities of machine intelligence. The purpose of these methods was to identify specific segments of the patient population. This ability enabled the pharmaceutical industry partners to integrate the results obtained in the initial stages of studies into subsequent studies, thus reducing the risk of failure in the development process.
Complex systems could be classified using approaches that retreated when they did not have a complete understanding, although this implied certain limitations. The data from clinical trials were often limited, with fewer than 500 participants, which was both a volume issue and a considerable expense. Therefore, the models applied to these datasets had to show caution when they were not convinced of their validity.
The assessment tools used by psychiatrists have proved remarkably useful and have considerable analytical power. The integration of a larger number of such scales into a study increased understanding of the patient profile, providing models with more distinct parameters for detection, although it was imperative that findings be verified by independent replication.
Academic-profile psychiatrists who incorporated multiple scales into their research achieved superior results.
This type of questions collected during interviews
A profound transformation is anticipated in everyday practice. Real-life data, wearable device information, speech latency and typing changes on mobile apps will become integral parts of healthcare. These subtle changes may signal the onset of depressive symptoms.
Geraci anticipated a future in which a replacement for genetic or MRI imaging tools will be developed, locally made, based on scales and other measurements. For example, while there is not yet a definitive model for the recommendation of the medicinal product escitalopram, elements of the anhedonia assessment scale, such as the satisfaction obtained from eating a preferred meal, can be incorporated into clinical practice.
This type of questions collected during interviews with patients has undeniable value, according to Geraci: if I start collecting these questions during interviews with patients, this becomes extremely valuable information .
The future models will come with specialized techniques. Clinics, in turn, can contribute through the transparency with which they present data and their attitude towards this area.
Geraci considered the common perception of AI to be incomplete, advocating the development of methods specifically tailored to patient populations. Its approach differs from traditional stratification in that it works with population factorization, considering heterogeneity from the start and treating the taxonomy of disease as an unresolved problem.
(References: 1. It is not possible to determine the exact amount of the aid to be granted. The following is a list of the official languages of the Republic of Moldova.